Hôpital Saint Vincent-de-Paul

Lille, Hauts-de-France 59020

1 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Eczema, Lymphoma, Mantle-Cell

Studies at this site

• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation
• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling